{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:14:09Z","timestamp":1793045649883,"version":"4.5.0"},"reference-count":15,"publisher":"SLACK, Inc.","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Refract Surg"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To compare the results of wavefront-guided custom LASIK and the Toric Implantable Collamer Lens (TICL) in the correction of myopic astigmatism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This observational, non-randomized study compared clinical efficacy results from the TICL's US Food and Drug Administration Clinical Trial and published Summaries of Safety and Effectiveness of two wavefront-guided lasers: STAR S4 CustomVue excimer laser system (VISX Inc) and LADARVision4000 Custom-Cornea excimer laser system (Alcon Laboratories Inc). Preoperative myopic refractive error was divided into two groups: \u22123.00 to \u22127.00 diopters (D) and \u22127.00 to \u221211.00 D.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>\n              The percentage of eyes with uncorrected visual acuity (UCVA) of 20\/20 and 20\/40 and predictability of manifest refraction spherical equivalent within \u00b10.50 and \u00b11.00 D in the three groups was similar with only one statistically significant difference (TICL versus Alcon within \u00b11.00 D: 97% versus 82%;\n              <jats:italic>P<\/jats:italic>\n              =.008). The TICL had significantly better postoperative best spectacle-corrected visual acuity (BSCVA) compared to preoperative BSCVA than both the VISX CustomVue and Alcon CustomCornea (\n              <jats:italic>P<\/jats:italic>\n              &lt;.001). The TICL postoperative UCVA outcomes compared to preoperative BSCVA were significantly better than Alcon CustomCornea outcomes (\n              <jats:italic>P<\/jats:italic>\n              &lt;.001). Additionally, almost half (48%) of the TICL cases had improvement in postoperative UCVA compared to preoperative BSCVA, whereas only 23% of the Alcon CustomCornea eyes showed improvement.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>\n              Although comparable in clinical efficacy outcomes, the TICL had a significantly better postoperative improvement in BSCVA and significantly better postoperative UCVA than preoperative BSCVA. The TICL can be considered as an alternative to LASIK through the full range of use. [\n              <jats:italic>J Refract Surg.<\/jats:italic>\n              2008;24:773\u2013778.]\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.3928\/1081597x-20081001-02","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T20:29:28Z","timestamp":1569443368000},"page":"773-778","source":"Crossref","is-referenced-by-count":18,"title":["Comparison of the Toric Implantable Collamer Lens and Custom Ablation LASIK for Myopic Astigmatism"],"prefix":"10.3928","volume":"24","author":[{"given":"Donald R.","family":"Sanders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica L.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.06.017"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(02)01511-0"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20030302-08"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200305000-00009"},{"key":"e_1_3_1_6_2","article-title":"Comparison of Implantable Contact Lens and laser assisted in situ keratomileusis (LASIK) for low myopia","author":"Sanders DR","unstructured":"Sanders DR, Vukich JA. Comparison of Implantable Contact Lens and laser assisted in situ keratomileusis (LASIK) for low myopia. Cornea. In press.","journal-title":"Cornea"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.03.026"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20030701-04"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.08.049"},{"key":"e_1_3_1_10_2","unstructured":"U.S. Food and Drug Administration Center for Devices and Radiological Health. Premarket Approval Application (PMA) Summary of Safety and Effectiveness data (PMA P930016\/S016). STAR S4 Active Trak excimer laser system and WaveS-can wavefront system. Available at: http:\/\/www.fda.gov\/cdrh\/pdf\/P930016S016.html. Accessed November 7 2006."},{"key":"e_1_3_1_11_2","unstructured":"U.S. Food and Drug Administration Center for Devices and Radiological Health. Premarket Approval Application (PMA) Summary of Safety and Effectiveness data (PMA P930016\/S021). STAR S4 IR excimer laser system with variable spot scanning (VSS) and WaveScan wavefront system. Available at: http:\/\/www.fda.gov\/cdrh\/pdf\/P930016S021.html. Accessed November 7 2006."},{"key":"e_1_3_1_12_2","unstructured":"U.S. Food and Drug Administration Center for Devices and Radiological Health. Premarket Approval Application (PMA) Summary of Safety and Effectiveness data (PMA P970043\/S015). Alcon Laboratories Inc. LADARVision 4000 excimer laser system. Available at: http:\/\/www.fda.gov\/cdrh\/pdf\/P970043S015.html. Accessed November 7 2006."},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01771-2"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20040901-10"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2004.12.050"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/02713680701329321"}],"container-title":["Journal of Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/ophthalmology\/refractive-surgery\/journals\/jrs\/2008-10-24-8\/%7B7082de23-66a6-4543-841d-502c1ad84a37%7D\/comparison-of-the-toric-implantable-collamer-lens-and-custom-ablation-lasik-for-myopic-astigmatism","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T18:42:23Z","timestamp":1731696143000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/1081597X-20081001-02"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.3928\/1081597X-20081001-02"],"URL":"https:\/\/doi.org\/10.3928\/1081597x-20081001-02","relation":{},"ISSN":["1081-597X"],"issn-type":[{"value":"1081-597X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}